November 14, 2019 by Chain Drug Review
NACDS, Steve Anderson, Substance use disorder (SUD) treatment
Featured Articles, Leading Headlines, Pharmacy
ARLINGTON, Va.– Substance use disorder (SUD) treatment could benefit from pharmacists’ accessibility and expertise, the National Association of Chain Drug Stores (NACDS) wrote in detailed letters to 15 Medicaid program directors. NACDS also called for action on policy recommendations designed to help prevent opioid abuse and addiction, while caring for those in pain. NACDS made
February 18, 2019 by Chain Drug Review
2019 NACDS Regional Chain Conference, Mark Panzer, Rebecca Buble, Steve Anderson
February 18, 2019, News
PALM BEACH, Fla. — The National Association of Chain Drug Stores’ campaign-style approach to the issues crucial for pharmacy value and viability dominated this month’s opening session of the 2019 NACDS Regional Chain Conference. NACDS’ top-priority issue of direct and indirect remuneration (DIR) fee reform headlined the discussion of the association’s “Access Agenda” — which
February 18, 2019 by Jeffrey Woldt
2019 NACDS Regional Chain Conference, DIR fees, Mark Panzer, Medicare Part D, NACDS, Steve Anderson
February 18, 2019, Opinion
The National Association of Chain Drug Stores was at the top of its game during the Regional Chain Conference in Palm Beach, Fla., earlier this month. Often overshadowed by the association’s larger events, this hidden gem provides attendees with an initial look at the objectives that NACDS and its members will pursue during the course
January 31, 2019 by Chain Drug Review
NACDS, pharmacists, pharmacy, Steve Anderson
Leading Headlines
ARLINGTON, Va. – The National Association of Chain Drug Stores has responded to “The Unsung Role of the Pharmacist in Patient Health,” a New York Times article published on Jan. 28 that emphasizes the increasingly important role of pharmacists in health care delivery. NACDS president and CEO Steve Anderson wrote, “This column validates further the competence,
January 10, 2019 by Steve Anderson
NACDS, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. In health policy, 2018 and 2019 could look a lot alike. In October, the National Association of Chain Drug Stores was invited to the White House for two bill-signing ceremonies in as many weeks: one for legislation related to drug
September 26, 2018 by Chain Drug Review
gag clauses, Know the Lowest Price Act (S. 2553), NACDS, Patient Right to Know Prices Act (S. 2554), Steve Anderson, U.S. House of Representatives
Featured Articles, Leading Headlines, Pharmacy
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) lauded Congressional leaders for their efforts to empower pharmacists help patients reduce out-of-pocket drug costs. The U.S. House of Representatives approved the Senate-passed versions of the Patient Right to Know Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), thus
September 19, 2018 by Chain Drug Review
National Association of Chain Drug Stores (NACDS, Patient Right to Know Prices Act (S. 2554), save money on prescription drugs by ending so-called “gag clauses”, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) praised the U.S. Senate’s passage last evening of the Patient Right to Know Prices Act (S. 2554). The bill would help patients in private plans save money on prescription drugs by ending so-called “gag clauses” that prevent pharmacists from telling patients they could save
September 17, 2018 by Chain Drug Review
Every Prescription Conveyed Securely Act (S. 2460), NACDS, National Association for Chain Drug Stores, Steve Anderson
Leading Headlines, Pharmacy
ARLINGTON, Va. – The U.S. Senate just passed a package of measures focused on the opioid abuse epidemic, including the Every Prescription Conveyed Securely Act (S. 2460), which is backed by the National Association of Chain Drug Stores (NACDS). The legislation would require electronic prescribing for Schedule II through V controlled substances prescriptions covered under
August 26, 2018 by Chain Drug Review
Mark Panzer, National Association of Chain Drug Stores (NACDS) Total Store Expo, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy
NACDS chairman of the board Mark Panzer, senior vice president, pharmacy, health and wellness of Albertsons Companies, described the value that NACDS members appreciate most. “In short, it’s about business community and intelligence, it’s about effective government advocacy, and it’s about powerful and practical information on policy,” Panzer explained. DENVER – The business program of
August 25, 2018 by Steve Anderson
2018 NACDS TSE, Steve Anderson
Leading Headlines
DENVER — Welcome to the 2018 NACDS Total Store Expo. This year’s event will be unlike anything else before it, because that is the nature of the transformation in which the industry is engaged. You will see the scope and magnitude of change in the content of each and every meeting between retailers and suppliers,
June 7, 2018 by Chain Drug Review
Gen. Michael Hayden, NACDS Total Store Expo, National Association of Chain Drug Stores, Steve Anderson
Leading Headlines, Retail News
ARLINGTON, Va. — With international relations and cybersecurity among the high-profile issues of the day, the National Association of Chain Drug Stores (NACDS) today announced a true expert on these issues, Gen. Michael Hayden, as the keynote speaker at the 2018 NACDS Total Store Expo. Gen. Hayden will speak during the event’s Business Program on
April 22, 2018 by Chain Drug Review
NACDS, Steve Anderson
Featured Articles, Issue 04-23-2018, Leading Headlines, News, Pharmacy, Retail News
ARLINGTON, Va. — In the currently chaotic public policy environment, the ability of the National Association of Chain Drug Stores to remain both focused and nimble in support of its industry has been a huge asset to the NACDS membership. As NACDS president and chief executive officer Steve Anderson pointed out earlier this year, the
April 17, 2018 by Chain Drug Review
NACDS, Opioid, Steve Anderson
Leading Headlines, Pharmacy, Retail News
ARLINGTON, Va. — The National Association of Chain Drug Stores has endorsed S. 2645, the Access to Increased Drug Disposal Act of 2018, which is consistent with the spirit of NACDS’ policy recommendations to help address the opioid abuse epidemic. Sen. Joni Ernst (R., Iowa) introduced the legislation, with the bipartisan original co-sponsorship of Sen. Chuck
April 5, 2018 by Chain Drug Review
DIR fee reform, Medicare Part D Rule, NACDS, Steve Anderson
Issues, Leading Headlines, Pharmacy
ARLINGTON, Va. – The National Association of Chain Drug Stores expressed appreciation to the Centers for Medicare and Medicaid Services (CMS) for provisions in the final 2019 Medicare Part D rule and in the 2019 Rate Announcement and Final Call Letter, which the agency released earlier this week. The agency signaled the potential for future